Why DNA testing kit makers are investing in China – South China Morning Post
What happened: China’s DNA market is attracting rising investment from equipment makers with applications ranging from cancer detection and treatment to prenatal screening. China’s DNA sequencing market is expected to reach RMB 18.3 billion by 2022.

Why it’s important: China’s growing market in DNA implies a future trend in the country’s biotech markets. According to research, the global DNA sequencing market could reach $22 billion by 2024 and China is expected to grow faster than it due to rising income and growing investments in healthcare infrastructure. Early stage diagnoses and other advancements in the medical field also help to ease the burden of China’s ailing national healthcare system.

Jiefei Liu is a Beijing based tech reporter. She focuses on the union of tech and content creation and loves agriculture. You can write to her at Jiefei@technode.com

Leave a comment

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.